Tiny Biotech Follows Big Stock Jump With Stock Offering Pricing; MCRB SlipsInvestors Business Daily • 08/13/20
Seres Therapeutics, Inc. Announces Pricing of Public Offering of 10,500,000 Shares of Common StockBusiness Wire • 08/13/20
Seres Therapeutics Skyrockets On Positive Pivotal Study Results For Microbiome TherapeuticBenzinga • 08/10/20
Seres Therapeutics stock rockets nearly fourfold after positive Phase 3 data on treatment for colon infectionsMarket Watch • 08/10/20
Seres Therapeutics Announces Positive Topline Results from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. difficile InfectionBusiness Wire • 08/10/20
Do Options Traders Know Something About Seres Therapeutics (MCRB) Stock We Don't?Zacks Investment Research • 08/07/20
Earnings Preview: Seres Therapeutics (MCRB) Q2 Earnings Expected to DeclineZacks Investment Research • 07/28/20
Seres Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business UpdatesBusiness Wire • 07/28/20
Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/10/20
Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/02/20
Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/05/19
Seres Therapeutics (MCRB) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/05/19
Seres Therapeutics, Inc. (MCRB) Shares March Higher, Can It Continue?Zacks Investment Research • 08/22/19
Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/06/19
Seres Therapeutics (MCRB) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/25/19
Seres Therapeutics (MCRB) CEO Eric Shaff on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/06/19
Seres Therapeutics (MCRB) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/02/19